Algernon Submits Investigational New Drug Application with U.S. FDA for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil for COVID-19
Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company, is pleased to announce that it has submitted an Investigational New Drug...
Sona Nanotech Engages MRIGlobal for COVID-19 Test Validation Studies
Sona Nanotech Inc. is pleased to announce the engagement of MRIGlobal, a leading applied scientific research organization, to provide analytical...
Naturally Splendid Provides Update for Phase 2 COVID 19 Clinical Trial
Naturally Splendid Enterprises Ltd. is pleased to provide the following update regarding preparation for a phase 2 clinical trial treatment...
BriaCell Files Patent Application for Novel Immune Therapies for Multiple Disease Indications
BriaCell Therapeutics has filed a provisional patent application with the U.S. Patent and Trademark Office outlining a novel vaccine platform...
Asia Green Biotechnology Corp. Updates Status of Continuing COVID-19 Research Activity with License Partners
Asia Green Biotechnology Corp. (CSE:ASIA) announced corporate developments.
Sirona Biochem Announces Change of Location Of Annual General Meeting
Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (US-OTC:SRBCF) announces that AGM will be held on Friday, May 22, 2020, at...
Naturally Splendid Announces LOI for Joint Venture with Biologic Pharmamedical Research for COVID 19 Clinical Trial
Naturally Splendid Enterprises Ltd. has entered into a Letter of Intent with Vancouver based Biologic Pharmamedical Research to form a...